Theralase Technologies Inc.
OTC: TLTFF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Roger John Dumoulin-White
- Employees
- 14
- Headquarters
- Toronto, Canada
- IPO year
- 2010
- Market cap
- $48.9M
- Website
- https://www.theralase.com
Loading TLTFF…
Loading profile data…Frequently asked questions about TLTFF
What does Theralase Technologies Inc. (TLTFF) do?
Theralase Technologies Inc., founded in Toronto, Canada in 1994, is a clinical-stage pharmaceutical company focused on the development of innovative therapies and medical devices. The company's pharmaceutical division specializes in the research and development of photo dynamic compounds (PDCs) and their drug formulations. These advanced treatme...
Where does TLTFF trade?
Theralase Technologies Inc. (TLTFF) trades on the Other OTC.
What sector is TLTFF in?
Theralase Technologies Inc. (TLTFF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Theralase Technologies Inc.?
Roger John Dumoulin-White is the chief executive officer of Theralase Technologies Inc. (TLTFF).
Where is Theralase Technologies Inc. headquartered?
Theralase Technologies Inc. is headquartered in Canada.
Does TLTFF pay a dividend?
Theralase Technologies Inc. (TLTFF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TLTFF go public?
Theralase Technologies Inc. (TLTFF) completed its initial public offering in 2010.